Skip to content

Archimedes Navigation System Guidance for Performance of Transbronchial Cryobiopsy in Diffuse Lung Disease-A Preliminary Report

Archimedes Navigation System Guidance for Performance of Transbronchial Cryobiopsy in Diffuse Lung Disease-A Preliminary Report

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800020148
Enrollment
Unknown
Registered
2018-12-17
Start date
2019-01-01
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diffuse lung disease

Interventions

system
Index test:Archimedes&#32
Gold Standard:Pathology

Sponsors

Henan People's Hosptial
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Diffuse bilateral lung diseases aged 18-75 years with unknown causes; 2. High resolution CT(HRCT) examination could not identify the cause of the disease;3. Interstitial pneumonia of unknown cause; 4. Patients and their families can understand and agree with the purpose of this study; 5. The patient signed the informed consent for examination.

Exclusion criteria

Exclusion criteria: 1. Inability to tolerate tracheal endoscopy under general anesthesia; 2. Long-term use of anticoagulants (warfarin or aspirin cannot be stopped) 3. Abnormal platelet function or platelet count (< 100*109); 4. Previous history of massive hemorrhage under bronchoscopy; 6. Severe cardiac insufficiency; 7. Severe lung diffusion dysfunction; 8. Pregnant or lactating.

Design outcomes

Primary

MeasureTime frame
bleeding;pneumothorax;SPE, SEN, ACC;

Countries

China

Contacts

Public ContactQuncheng Zhang

He'nan People's Hosptial

zhang.quncheng0813@hotmail.com+86 15038142486

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026